Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

RAN GTPase as a target for cancer therapy: Ran binding proteins.

Doherty KJ, McKay C, Chan KK, El-Tanani MK.

Curr Mol Med. 2011 Nov;11(8):686-95. Review.

PMID:
21902650
2.

Osteopontin can act as an effector for a germline mutation of BRCA1 in malignant transformation of breast cancer-related cells.

El-Tanani MK, Yuen HF, Shi Z, Platt-Higgins A, Buckley NE, Mullan PB, Harkin DP, Johnston PG, Rudland PS.

Cancer Sci. 2010 Jun;101(6):1354-60. doi: 10.1111/j.1349-7006.2010.01561.x. Epub 2010 Mar 10.

3.

Interferon-induced transmembrane 3 binds osteopontin in vitro: expressed in vivo IFITM3 reduced OPN expression.

El-Tanani MK, Jin D, Campbell FC, Johnston PG.

Oncogene. 2010 Feb 4;29(5):752-62. doi: 10.1038/onc.2009.379. Epub 2009 Nov 9.

PMID:
19901966
4.

Identification of genes differentially expressed between benign and osteopontin transformed rat mammary epithelial cells.

Kurisetty VV, Johnston PG, Rudland PS, El-Tanani MK.

BMC Res Notes. 2009 Feb 3;2:15. doi: 10.1186/1756-0500-2-15.

5.

Osteopontin: a new role for a familiar actor.

Johnston NI, El-Tanani MK.

Breast Cancer Res. 2008;10(6):306. doi: 10.1186/bcr2199. Epub 2008 Dec 1.

6.

RAN GTPase is an effector of the invasive/metastatic phenotype induced by osteopontin.

Kurisetty VV, Johnston PG, Johnston N, Erwin P, Crowe P, Fernig DG, Campbell FC, Anderson IP, Rudland PS, El-Tanani MK.

Oncogene. 2008 Dec 4;27(57):7139-49. doi: 10.1038/onc.2008.325. Epub 2008 Sep 15.

PMID:
18794800
7.

Osteopontin as a target for cancer therapy.

Johnston NI, Gunasekharan VK, Ravindranath A, O'Connell C, Johnston PG, El-Tanani MK.

Front Biosci. 2008 May 1;13:4361-72. Review.

PMID:
18508515
8.

Role of osteopontin in cellular signaling and metastatic phenotype.

El-Tanani MK.

Front Biosci. 2008 May 1;13:4276-84. Review.

PMID:
18508510
9.

The role of LEF/TCF factors in neoplastic transformation.

Ravindranath A, O'Connell A, Johnston PG, El-Tanani MK.

Curr Mol Med. 2008 Feb;8(1):38-50. Review.

PMID:
18289012
10.
11.

The regulation and role of osteopontin in malignant transformation and cancer.

El-Tanani MK, Campbell FC, Kurisetty V, Jin D, McCann M, Rudland PS.

Cytokine Growth Factor Rev. 2006 Dec;17(6):463-74. Epub 2006 Nov 17. Review.

PMID:
17113338
12.

BRCA1 suppresses osteopontin-mediated breast cancer.

El-Tanani MK, Campbell FC, Crowe P, Erwin P, Harkin DP, Pharoah P, Ponder B, Rudland PS.

J Biol Chem. 2006 Sep 8;281(36):26587-601. Epub 2006 Jun 28.

13.

Regulatory region of metastasis-inducing DNA is the binding site for T cell factor-4.

El-Tanani MK, Barraclough R, Wilkinson MC, Rudland PS.

Oncogene. 2001 Mar 29;20(14):1793-7.

14.

Transcription factor, BTF3, and the AF-1 function of the estrogen receptor.

el-Tanani MK, Green CD.

Biochem Soc Trans. 1998 Aug;26(3):S252. No abstract available.

PMID:
9765971
15.

Two separate mechanisms for ligand-independent activation of the estrogen receptor.

El-Tanani MK, Green CD.

Mol Endocrinol. 1997 Jun;11(7):928-37.

PMID:
9178752
16.
17.

Interaction between estradiol and cAMP in the regulation of specific gene expression.

el-Tanani MK, Green CD.

Mol Cell Endocrinol. 1996 Nov 29;124(1-2):71-7.

PMID:
9027326
18.

Synergism between oestradiol and cAMP for specific gene transcription in breast cancer cells.

el-Tanani MK, Green CD.

Biochem Soc Trans. 1996 Aug;24(3):344S. No abstract available.

PMID:
8878888
19.

Oestrogen and insulin interact at the level of transcription in breast cancer cells.

el-Tanani MK, Green CD.

Biochem Soc Trans. 1996 Aug;24(3):343S. No abstract available.

PMID:
8878887
20.

Insulin/IGF-1 modulation of the expression of two estrogen-induced genes in MCF-7 cells.

el-Tanani MK, Green CD.

Mol Cell Endocrinol. 1996 Jul 23;121(1):29-35.

PMID:
8865163
21.

Hormone regulation of gene transcription in human breast cancer cells.

el-Tanani MK, Green CD.

Biochem Soc Trans. 1995 Nov;23(4):589S. No abstract available.

PMID:
8654774
22.

Oestrogen-induced genes, pLIV-1 and pS2, respond divergently to other steroid hormones in MCF-7 cells.

el-Tanani MK, Green CD.

Mol Cell Endocrinol. 1995 Apr 28;111(1):75-81.

PMID:
7649356

Supplemental Content

Loading ...
Support Center